Evidence map›Paper›PMID 27520529›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]

Terpinen-4-ol, tyrosol, and β-lapachone as potential antifungals against dimorphic fungi.

Raimunda Sâmia Nogueira Brilhante, Érica Pacheco Caetano, Rita Amanda Chaves de Lima, Francisca Jakelyne de Farias Marques, Débora de Souza Collares Maia Castelo-Branco, Charlline Vládia Silva de Melo, Glaucia Morgana de Melo Guedes, Jonathas Sales de Oliveira, Zoilo Pires de Camargo, José Luciano Bezerra Moreira and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Activity of Common Thyme (Molecules (Basel, Switzerland) · 2024
    Article
  5. Antifungal activity of β-lapachone against a fluconazole-resistant Candida auris strain.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  6. Article
  7. Review
  8. Chemical Characterization ofMolecules (Basel, Switzerland) · 2023
    Article
  9. Essential Oils as a Good Weapon against Drug-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  10. Essential Oils in Respiratory Mycosis: A Review.Molecules (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Article
  13. Antifungal Activity ofMolecules (Basel, Switzerland) · 2021
    Article
  14. Uncharted Source of Medicinal Products: The Case of theMedicines (Basel, Switzerland) · 2020
    Review
  15. Review
  16. Antifungal activity of Gallesia integrifolia fruit essential oil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2018
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Raimunda Sâmia Nogueira BrilhanteFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil; Federal University of Ceará, Fortaleza, Postgraduate Program in Medical Sciences, CE, Brazil. Electronic address: brilhante@ufc.br.
Érica Pacheco CaetanoFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil.
Rita Amanda Chaves de LimaFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil.
Francisca Jakelyne de Farias MarquesFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil.
Débora de Souza Collares Maia Castelo-BrancoFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil.
Charlline Vládia Silva de MeloFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil.
Glaucia Morgana de Melo GuedesFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil.
Jonathas Sales de OliveiraFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil.
Zoilo Pires de CamargoFederal University of São Paulo, Department of Microbiology, Immunology and Parasitology, Cellular Biology Division, São Paulo, SP, Brazil.
José Luciano Bezerra MoreiraFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil.
André Jalles MonteiroFederal University of Ceará, Fortaleza, Department of Statistics and Applied Mathematics, Fortaleza, CE, Brazil.
Tereza de Jesus Pinheiro Gomes BandeiraChristus College - Unichristus, Fortaleza, School of Medicine, Forteleza, CE, Brazil.
Rossana de Aguiar CordeiroFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil; Federal University of Ceará, Fortaleza, Postgraduate Program in Medical Sciences, CE, Brazil.
Marcos Fábio Gadelha RochaFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil; State University of Ceará, Fortaleza, Postgraduate Program in Veterinary Sciences, Forteleza, CE, Brazil.
José Júlio Costa SidrimFederal University of Ceará, Fortaleza, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, CE, Brazil; Federal University of Ceará, Fortaleza, Postgraduate Program in Medical Sciences, CE, Brazil.
Universidade Federal do Ceará · BRUnichristus · BRUniversidade Estadual do Ceará · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the in vitro antifungal activity of terpinen-4-ol, tyrosol, and β-lapachone against strains of Coccidioides posadasii in filamentous phase (n=22) and Histoplasma capsulatum in both filamentous (n=40) and yeast phases (n=13), using the broth dilution methods as described by the Clinical and Laboratory Standards Institute, to determine the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of these compounds. The mechanisms of action of these compounds were also investigated by analyzing their effect on cell membrane permeability and ergosterol synthesis. The MIC and MFCf these compounds against C. posadasii, mycelial H. capsulatum, and yeast-like H. capsulatum, were in the following ranges: 350-5720μg/mL, 20-2860μg/mL, and 40-1420μg/mL, respectively for terpinen-4-ol; 250-4000μg/mL, 30-2000μg/mL, and 10-1000μg/mL, respectively, for tyrosol; and 0.48-7.8μg/mL, 0.25-16μg/mL, and 0.125-4μg/mL, respectively for β-lapachone. These compounds showed a decrease in MIC when the samples were subjected to osmotic stress, suggesting that the compounds acted on the fungal membrane. All the compounds were able to reduce the ergosterol content of the fungal strains. Finally, tyrosol was able to cause a leakage of intracellular molecules.

Indexed as

Antifungal AgentsCell Membrane PermeabilityErgosterolFungiMicrobial Sensitivity TestsNaphthoquinonesOsmotic PressurePhenylethyl AlcoholTerpenes4-hydroxyphenylethanolAntifungal Agentsbeta-lapachoneErgosterolNaphthoquinonesPhenylethyl AlcoholTerpenesterpinenol-4Dimorphic fungiInhibitory effectTerpinen-4-olTyrosolβ-Lapachone

Identifiers

PMID27520529
PMCPMC5052391
OpenAlexW2495784311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.